ClinicalTrials.Veeva

Menu

Patient Outcomes After Hepatic Artery Infusion Pump Placement

Mayo Clinic logo

Mayo Clinic

Status

Completed

Conditions

Colorectal Liver Metastases
Colorectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05468593
22-003190

Details and patient eligibility

About

The purpose of this study is to evaluate the surgical outcomes and the quality of life (QOL) in patients undergoing hepatic artery infusion pump placement for colorectal liver metastases (CRLM).

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who receive a Hepatic Artery Infusion Pump at Mayo Clinic Rochester for liver metastases from colorectal cancer.
  • Written consent.

Exclusion criteria

  • Absence of written consent.
  • Systemic disease.
  • Pregnancy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems